Bettina Ryll is the founder of the Melanoma Patient Network Europe and was member of the first EU Cancer Mission Board. A physician by training and with a PhD in Biomedical Sciences from University College London, she became a patient advocate after losing her husband to cancer.
Her work focuses on patient-centric innovation, covering the full spectrum from basic research over successful translation and clinical trials to timely and equitable implementation. Most recently and trigged by her work on the EU Cancer Mission Board, her particular interest has been how to best leverage the potential of personalized medicine for patients and society through novel forms of collaboration and the support of health policy and governance.
Bettina Ryll currently works as strategist for Vision Zero Cancer, a mission-driven innovation ecosystem in health financed by Sweden’s Innovation Agency Vinnova.